JAMA Internal Medicine
banner
jamainternalmed.com
JAMA Internal Medicine
@jamainternalmed.com
JAMA Internal Medicine is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.

🌐 JAMAInternalMed.com
A Singapore-based RCT found that a single mailed reminder is as effective as more complex behavioral interventions for increasing mammogram uptake among overdue repeat screeners. ja.ma/43fA9KY
November 10, 2025 at 4:30 PM
Assoc. Editor Giselle Corbie, MD, MSc, and author Lynda Powell, PhD, discuss strategies for supporting lasting lifestyle changes and long-term outcomes for patients with metabolic syndrome.

#AHA25 @ahascience.bsky.social

🎧 Listen now: ja.ma/3WMJTc0
November 9, 2025 at 11:41 PM
Reposted by JAMA Internal Medicine
In this #AHA25 edition of the JAMA Editor’s Summary podcast, Gregory Curfman, MD, Philip Greenland, MD, and Robert Bonow, MD, MS, review key JAMA Network articles, including:

➡️ Coffee and #AFib,
➡️ DASH-patterned groceries,
➡️ Oral PCSK9 inhibitor enlicitide, and more.

🎧 Listen now: ja.ma/47MpAAj
November 9, 2025 at 11:35 PM
Reposted by JAMA Internal Medicine
💾 Save this thread! Check out these key findings from today's JAMA, @jamacardiology.com, @jamainternalmed.com, and
@jamanetworkopen.com presentations at #AHA25. 🧵

Adding coronary CT angiography to traditional risk scores modestly improved prediction of first coronary events. ja.ma/4oyzvko
November 9, 2025 at 11:20 PM
A 6-month habit-based group lifestyle intervention added to routine education and activity monitoring improved the proportion of patients with sustained metabolic syndrome remission.

#AHA25 @ahascience.bsky.social

ja.ma/4oYXnx9
November 9, 2025 at 10:30 PM
A randomized clinical trial published in JAMA found that patients with AF who consumed caffeinated coffee had a lower risk of recurrent AF or atrial flutter compared with those who abstained.

#AHA25 #AFib @ahascience.bsky.social

ja.ma/43UFh7x
November 9, 2025 at 5:00 PM
📊 Research Summary from @jama.com: Adults with #AFib who drank at least one cup of caffeinated coffee daily after successful cardioversion had a lower risk of recurrence than those who abstained from coffee and caffeine.

#AHA25 @ahascience.bsky.social

ja.ma/47K8tPT
November 9, 2025 at 3:20 PM
From @jama.com: Patients with #AFib who continued their usual caffeinated coffee intake after cardioversion experienced less recurrence of AF or atrial flutter compared to those who abstained from coffee and caffeine.

#AHA25 @ahascience.bsky.social

ja.ma/3XolIkd
November 9, 2025 at 3:05 PM
#HormoneTherapy reduces vasomotor symptoms w/o increasing #cardiovascular risk in postmenopausal women aged 50 to 59, but raises cardiovascular risk in those over 70, finds this secondary analysis of 2 RCTs.

ja.ma/47yoNTu
November 9, 2025 at 1:00 PM
From @jama.com: Liberal transfusion after major surgery did not reduce death or major cardiac event rates compared to restrictive thresholds in high-risk patients.

#AHA25 @ahascience.bsky.social

ja.ma/47BjliI
November 8, 2025 at 10:25 PM
From @jama.com: Among people with PAD and no #diabetes, metformin treatment for 6 months did not result in improvements in walking ability or secondary outcomes vs placebo.

#AHA25 @ahascience.bsky.social

ja.ma/47yiLnq
November 8, 2025 at 4:15 PM
Special Communication: Doubling of early-onset cancer incidence since 1992 in US adults <50 reflects increased diagnosis; mortality remains stable or declines. ja.ma/3WDtFls
November 8, 2025 at 1:00 PM
Reposted by JAMA Internal Medicine
🧵 JAMA, @jamainternalmed.com, and @jamanetworkopen.com conclude #KidneyWk with impactful findings:

In stable AKI patients, indication-based dialysis enabled faster liberation from dialysis and reduced health care resource use compared to conventional thrice-weekly treatment.

ja.ma/4nIK3Mo
November 8, 2025 at 1:01 AM
💬 @jama.com Editorial: #SGLT2 inhibitor treatment benefits extend to people with CKD and low albuminuria, as well as those with advanced #KidneyDisease, supporting wider use.

#KidneyWk @asnkidney.bsky.social

ja.ma/4nFSM29
November 8, 2025 at 12:50 AM
From @jama.com: #SGLT2 inhibitors slow kidney decline consistently across CKD severity and albuminuria range, supporting their routine use for kidney health.

#KidneyWK @asnkidney.bsky.social

ja.ma/47tGDsa
November 8, 2025 at 12:45 AM
From <a href="https://bsky.app/profile/did:plc:q5ogl3twkcqyhvz4zebonw3z" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky-mention">@jama.com: Among more than 800 000 CKD-PC participants, discordance between cystatin C and creatinine eGFR values was associated with increased risk of death, cardiovascular events, and kidney failure.

#KidneyWK <a href="https://bsky.app/profile/did:plc:7o2r67qqxflcit2osd2wu7ti" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky-mention">@asnkidney.bsky.social

ja.ma/47uzqbn
November 8, 2025 at 12:30 AM
💬 Editorial: Estrella et al show that integrated cystatin C and creatinine measurements improve CKD assessment compared to single-marker estimates.

#KidneyWK

ja.ma/3LxhhRy
November 8, 2025 at 12:30 AM
💬 @jama.com Editorial: The LIBERATE-D trial shows conservative dialysis—guided by A-E-I-O-U indications and asking "Why"—promotes earlier kidney recovery and fewer dialysis sessions in AKI.

#KidneyWK @asnkidney.bsky.social

ja.ma/4hOkM1W
November 8, 2025 at 12:20 AM
From @jama.com: In stable AKI patients, indication-based dialysis enabled faster liberation from dialysis and reduced health care resource use compared to conventional thrice-weekly treatment.

#KidneyWK @asnkidney.bsky.social

ja.ma/43Zf33H
November 8, 2025 at 12:15 AM
Among Hispanic and Latino adults receiving in-center hemodialysis, a culturally tailored community health worker intervention modestly reduced interdialytic weight gain and improved adherence and patient activation compared to standard care.

#KidneyWK ja.ma/49AwhYP
November 7, 2025 at 11:55 PM
RCT: In postmenopausal women, elinzanetant reduced vasomotor symptoms compared to placebo at 12 weeks, with continued benefits in frequency, sleep, and quality of life over 52 weeks, while maintaining safety. ja.ma/4hH0lE8
November 7, 2025 at 1:00 PM
RCT: Among 450 participants, Azelastine nasal spray was associated with a reduced incidence of lab-confirmed SARS-CoV-2 respiratory infections (2.2% compared to 6.7% with placebo). ja.ma/47ZMQMz
November 6, 2025 at 1:00 PM
Venture capital investments by academic medical centers in health care companies more than doubled from 2014 to 2024, totaling $24.2 billion and supporting mostly early-stage ventures.

ja.ma/47K3wGF
November 5, 2025 at 1:00 PM
Liraglutide addition for Chinese patients with type 2 diabetes and minor AIS or high-risk TIA reduced 90-day stroke recurrence and improved functional outcomes. ja.ma/43NALaM
November 3, 2025 at 4:30 PM
Viewpoint: #Telehealth has improved health care access for individuals experiencing homelessness by reducing barriers, although challenges like phone security and social interaction remain to be addressed. ja.ma/4oePNP3
November 2, 2025 at 11:00 AM